Jack Leiter shut down from rehab with biceps soreness, return timeline unclear

What happened

Jack Leiter's road back to the Texas Rangers rotation has hit another detour. The Rangers have temporarily shut down the right-hander after biceps soreness emerged during his rehab assignment, per MLB.com's Zach Sweat. Manager Skip Schumaker said the club will "reevaluate what that looks like in the next couple of days," leaving the timeline for Leiter's return genuinely open.

Leiter had been working back from arthroscopic ankle surgery he underwent in late June. The biceps soreness is a separate complication — one that arrived while he was on a Triple-A rehab assignment — and has now placed a hold on what had already been a delayed return.

Why it matters

Leiter has not taken the mound for Texas since June 18, when he surrendered six earned runs across four innings in a loss to the Twins that ended 9-3. That outing was the third consecutive rough start for the 26-year-old, and it came at a moment when the Rangers could least afford to lose a rotation arm. The club has been grinding through the second half without him, and the latest development means that grinding continues — with no firm date attached.

The timing is particularly pointed given where Texas sits in the standings. The Rangers are 70-73 (.490), sitting 2nd in the AL West, 3 games back, and ranked 5th in the Wild Card race, 2.0 games relative to the cut line, on a two-game losing streak. Every rotation start between now and the end of the regular season carries weight, and Leiter's absence removes a potential option from the back of the queue just as the calendar is running short.

The roster mechanics add another layer of context. Under general league rules, pitchers on rehab assignments have up to 30 days before a club must activate them or make another roster decision. A temporary shutdown resets the operational picture without necessarily resolving it — the Rangers will need clarity on the biceps before any return timetable can be responsibly discussed.

The numbers

Leiter's 2026 season line, before the ankle surgery ended his year in June, reads as a tale of two metrics. The surface number — a 5.29 ERA across 15 starts and 80 innings — is the kind of figure that generates roster conversations. But the fielding-independent measures tell a more complicated story.

His SIERA sits at 4.21, his xFIP at 4.24, his FIP at 4.75, and his xERA at 4.83. Each of those figures lands meaningfully below the ERA, and each, per the reporting, suggests that positive regression would be on the way for Leiter if he returns this year. The gap between what the ball-in-play results say and what the process-based metrics say is wide enough to matter — though whether Leiter gets the innings to close that gap in 2026 is now the operative question.

For comparison, Leiter posted a 3.86 ERA across 29 starts and 152 2/3 innings in 2025 — his first full season in the majors, and the year that established him as a legitimate rotation piece rather than a prospect still finding his footing. The former second overall pick's 2026 ERA, viewed alongside those underlying numbers, looks more like a rough patch than a structural decline. The biceps soreness, however, is not a metrics problem.

Where the club stands

The Rangers enter the weekend at 70-73 (.490), sitting 2nd in the AL West and 3 games back of the division lead. In the Wild Card picture, they rank 5th, 2.0 games relative to the cut line — close enough to matter, distant enough to feel the pressure of a two-game losing streak.

The upcoming schedule offers no soft landings. Texas is in Milwaukee on Saturday, August 29, with Cal Quantrill taking the ball against Shane Drohan, then returns Sunday, August 30, with Kumar Rocker opposing Dustin May. The club comes home Monday, August 31, for a matchup against the Athletics, where Jacob deGrom is the probable starter against Gage Jump.

That three-game stretch — two road games against the Brewers, then a home opener against the Athletics — will tell the Rangers something about whether they can stabilize before September's expanded roster rules take effect. Under general league mechanics, clubs can carry 28 players from September 1 through the end of the regular season, which opens up flexibility for depth moves. Whether Leiter is anywhere near that conversation depends entirely on what the next few days of evaluation produce.

What we don't know yet

Schumaker's "next couple of days" framing is the only timetable on record, and it is a window for evaluation, not a return date. The nature and severity of the biceps soreness has not been detailed in the reporting. It is not known whether the soreness will require additional imaging, a period of rest, or any further intervention — the club has not said, and Zach Sweat's report for MLB.com does not specify.

What is clear is that Leiter will not be rejoining the rotation imminently. What remains unclear is whether "temporarily shut down" means days or something longer. The Rangers have not characterized this as anything beyond a pause, but a pause with no end date attached is its own kind of uncertainty.

What to watch

### When could Leiter return to his rehab assignment?

The Rangers have said they will reevaluate in the next couple of days, per Schumaker's comments reported by MLB.com's Zach Sweat. That evaluation is the next concrete checkpoint — if the biceps soreness resolves quickly, the rehab assignment could resume. If it does not, the club will face a different set of decisions about how to handle Leiter's roster status as September approaches.

Beyond the immediate medical picture, watch how Texas manages its rotation over the next week. With deGrom lined up for Monday and Rocker and Quantrill handling the Milwaukee series, the Rangers have established arms in place. But a club sitting 2.0 games outside the Wild Card cut line in late August has limited margin for rotation volatility, and Leiter's absence — now extended by a second issue — is a variable that does not resolve itself.

The broader question, one the fielding-independent numbers quietly raise, is what a healthy Leiter looks like in a pennant-race context. The SIERA, xFIP, FIP, and xERA all point toward a pitcher whose results have run behind his process. That is a useful thing to know. It is also, at the moment, entirely theoretical.